Yumiko Sekiya

1.1k total citations
14 papers, 847 citations indexed

About

Yumiko Sekiya is a scholar working on Epidemiology, Hepatology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Yumiko Sekiya has authored 14 papers receiving a total of 847 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 4 papers in Hepatology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Yumiko Sekiya's work include Liver Disease Diagnosis and Treatment (4 papers), Liver physiology and pathology (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). Yumiko Sekiya is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), Liver physiology and pathology (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). Yumiko Sekiya collaborates with scholars based in Japan and United States. Yumiko Sekiya's co-authors include Kazuo Ikeda, Norifumi Kawada, Katsutoshi Yoshizato, Tomohiro Ogawa, Masashi Iizuka, Masaru Enomoto, Hideki Fujii, Tohru Ozawa, Masamichi Satoh and Takayuki Nakagawa and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Gut and Biochemical and Biophysical Research Communications.

In The Last Decade

Yumiko Sekiya

14 papers receiving 835 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yumiko Sekiya Japan 11 404 322 246 231 113 14 847
Eoghan O’Duibhir United Kingdom 16 716 1.8× 244 0.8× 236 1.0× 417 1.8× 346 3.1× 19 1.4k
Zhong Xu China 18 417 1.0× 303 0.9× 176 0.7× 97 0.4× 175 1.5× 48 882
Simona Gallo Italy 13 384 1.0× 103 0.3× 66 0.3× 84 0.4× 114 1.0× 24 716
Lisa Prichard United States 8 354 0.9× 110 0.3× 78 0.3× 93 0.4× 68 0.6× 9 651
Valentina Sala Italy 15 448 1.1× 102 0.3× 82 0.3× 71 0.3× 125 1.1× 24 886
Li-Ching Lin Taiwan 20 393 1.0× 204 0.6× 97 0.4× 83 0.4× 112 1.0× 27 890
Kazunori Yoshimura Japan 15 270 0.7× 42 0.1× 148 0.6× 160 0.7× 97 0.9× 41 621
Ziman Zhu China 16 612 1.5× 430 1.3× 113 0.5× 87 0.4× 82 0.7× 47 962
Hongliang Luo China 16 316 0.8× 239 0.7× 69 0.3× 45 0.2× 98 0.9× 63 735
M. C. A. Puntis United Kingdom 14 235 0.6× 96 0.3× 60 0.2× 156 0.7× 111 1.0× 26 645

Countries citing papers authored by Yumiko Sekiya

Since Specialization
Citations

This map shows the geographic impact of Yumiko Sekiya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yumiko Sekiya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yumiko Sekiya more than expected).

Fields of papers citing papers by Yumiko Sekiya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yumiko Sekiya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yumiko Sekiya. The network helps show where Yumiko Sekiya may publish in the future.

Co-authorship network of co-authors of Yumiko Sekiya

This figure shows the co-authorship network connecting the top 25 collaborators of Yumiko Sekiya. A scholar is included among the top collaborators of Yumiko Sekiya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yumiko Sekiya. Yumiko Sekiya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Nakamura, Keiko, Daisuke Takamatsu, Mariko Harada, et al.. (2025). Nisin A Treatment to Protect Honey Bee Larvae from European Foulbrood Disease. Probiotics and Antimicrobial Proteins. 17(5). 3587–3594. 1 indexed citations
2.
Sekiya, Yumiko, et al.. (2021). Evaluation of a simultaneous adsorption device for cytokines and platelet–neutrophil complexes in vitro and in a rabbit acute lung injury model. Intensive Care Medicine Experimental. 9(1). 49–49. 3 indexed citations
3.
Okazaki, Seiji, Takehiro Takahashi, Tomokatsu Iwamura, et al.. (2014). HIS-388, a Novel Orally Active and Long-Acting 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor, Ameliorates Insulin Sensitivity and Glucose Intolerance in Diet-Induced Obesity and Nongenetic Type 2 Diabetic Murine Models. Journal of Pharmacology and Experimental Therapeutics. 351(1). 181–189. 17 indexed citations
4.
Enomoto, Masaru, Hideki Fujii, Yumiko Sekiya, et al.. (2012). MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis. Gut. 61(11). 1600–1609. 209 indexed citations
5.
Kaneko, H., Hiroshi Ueda, Shinichi Yamaguchi, et al.. (2012). Discovery and structure–activity relationship of 2,6-disubstituted pyrazines, potent and selective inhibitors of protein kinase CK2. Bioorganic & Medicinal Chemistry Letters. 22(13). 4358–4361. 16 indexed citations
6.
Sekiya, Yumiko, Tomohiro Ogawa, Katsutoshi Yoshizato, Kazuo Ikeda, & Norifumi Kawada. (2011). Suppression of hepatic stellate cell activation by microRNA-29b. Biochemical and Biophysical Research Communications. 412(1). 74–79. 143 indexed citations
7.
Thủy, Lê Thị Thanh, Takashi Morita, Kayo Yoshida, et al.. (2011). Promotion of Liver and Lung Tumorigenesis in DEN-Treated Cytoglobin-Deficient Mice. American Journal Of Pathology. 179(2). 1050–1060. 77 indexed citations
8.
Sekiya, Yumiko, Tomohiro Ogawa, Masashi Iizuka, et al.. (2010). Down‐regulation of cyclin E1 expression by microrna‐195 accounts for interferon‐β‐induced inhibition of hepatic stellate cell proliferation. Journal of Cellular Physiology. 226(10). 2535–2542. 71 indexed citations
9.
Ogawa, Tomohiro, Masashi Iizuka, Yumiko Sekiya, et al.. (2009). Suppression of type I collagen production by microRNA-29b in cultured human stellate cells. Biochemical and Biophysical Research Communications. 391(1). 316–321. 117 indexed citations
10.
Nakagawa, Takayuki, Yumiko Sekiya, Tohru Ozawa, et al.. (2005). Gene transfer of GLT‐1, a glutamate transporter, into the nucleus accumbens shell attenuates methamphetamine‐ and morphine‐induced conditioned place preference in rats. European Journal of Neuroscience. 22(11). 2744–2754. 64 indexed citations
11.
Yamada, Masateru, Susumu Katsuma, Tetsuya Adachi, et al.. (2005). Inhibition of protein kinase CK2 prevents the progression of glomerulonephritis. Proceedings of the National Academy of Sciences. 102(21). 7736–7741. 69 indexed citations
12.
Ozawa, Tohru, Takayuki Nakagawa, Yumiko Sekiya, Masabumi Minami, & Masamichi Satoh. (2004). Effect of gene transfer of GLT‐1, a glutamate transporter, into the locus coeruleus by recombinant adenoviruses on morphine physical dependence in rats. European Journal of Neuroscience. 19(1). 221–226. 33 indexed citations
13.
Sekiya, Yumiko, Takayuki Nakagawa, Tohru Ozawa, Masabumi Minami, & Masamichi Satoh. (2003). Facilitation of morphine withdrawal symptoms and morphine-induced conditioned place preference by a glutamate transporter inhibitor dl-threo-β-benzyloxyaspartate in rats. European Journal of Pharmacology. 485(1-3). 201–210. 21 indexed citations
14.
Sekiya, Yumiko, et al.. (1992). [A chronic alcoholic patient with the development of frank diabetes after heavy drinking and perfect improvement following abstinence from alcohol].. PubMed. 27(3). 276–83. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026